| Substance | Condition | Seq | Src | PMID | Dtl | Title |
| EGCG | Epstein-Barr Virus Infection | 3 | PM | 33629943 | 📋 | (-)-Epigallocatechin-3-gallate inhibits EBV lytic replication via targeting LMP1-mediated MAPK signal axes |
| EGCG | Epstein-Barr Virus Infection | 4 | PM | 29399111 | 📋 | (-)-Epigallocatechin-3-gallate inhibition of Epstein-Barr virus spontaneous lytic infection involves downregulation of latent membrane protein 1 |
| EGCG | Epstein-Barr Virus Infection | 2 | PM | 15355641 | 📋 | [Epigallocatechin-3-gallate interferes with EBV-encoding AP-1 signal transduction pathway] |
| EGCG | Epstein-Barr Virus Infection | 1 | PM | 12589821 | 📋 | Inhibition of Epstein-Barr Virus Lytic Cycle by (-)-Epigallocatechin Gallate |
| EGCG | Herpes Simplex Infection | 3 | PM | 33390306 | 📋 | Effects of epigallocatechin-3-gallate and acyclovir on herpes simplex virus type 1 infection in oral epithelial cells |
| EGCG | Herpes Simplex Infection | 1 | PM | 26548726 | 📋 | Topical Lipophilic epigallocatechin-3-gallate on Herpes Labialis: A Phase II Clinical Trial of AverTeaX Formula |
| EGCG | Herpes Simplex Infection | 2 | PM | 18195068 | 📋 | Epigallocatechin Gallate Inactivates Clinical Isolates of Herpes Simplex Virus |
| EGCG | Human Herpesvirus 8 Infection | 1 | PM | 29267216 | 📋 | Epigallocatechin-3-Gallate Suppresses Human Herpesvirus 8 Replication and Induces ROS Leading to Apoptosis and Autophagy in Primary Effusion Lymphoma Cells |
